Motilal Oswal Large and Midcap Fund

(An open ended equity scheme investing in both large cap and mid cap stocks)

July 2023

Fund Manager
For Equity Component
Mr. Aditya Khemani
Managing this fund since inception.
He has overall 14 years of experience.
For Debt Component since Inception
Mr. Rakesh Shetty
Managing this fund since 22-Nov-2022
He has a rich experience of more than 14 years
For Foreign Securities
Mr. Ankush Sood
He has been appointed as the Fund Manager for
Foreign securities w.e.f. November 11, 2022.
Benchmark:
NIFTY Large Midcap 250 TRI
Monthly AAUM
₹ 1,891.80 cr
Latest AUM (31-July-2023)
₹ 1,952.85 cr
Market Capitalization
Market Cap
Weightage (%)
Large Cap
45%
Mid Cap
36%
Small Cap
20%
Top 5 Stocks
Stocks
(%) of Holding

Trent Ltd

6.5

Global Health Ltd

5.8

ICICI Bank Ltd

5.5

Fortis Healthcare Ltd

5.2

Infosys Ltd

5.1

Category Large and Midcap Fund
Date of Allotment 17-October-2019
Continuous Offer Minimum Application Amount : ₹ 500/- and in
multiples of ₹1 /- thereafter.
Additional Application Amount : ₹ 500/- and in
multiples of ₹1/- thereafter.
Redemption proceeds Normally within 2 Business days from acceptance of redemption request.
Entry / Exit Load Entry Load: Nil
1% - If redeemed on or before 15 days from the date of allotment. Nil - If redeemed after 15 days from the date of allotment. A switch-out or a withdrawal shall also be subjected to the Exit Load like any Redemption. No Exit Load applies for switch between Motilal Oswal Focused Fund, Motilal Oswal Midcap Fund, Motilal Oswal Flexi Cap Fund, Motilal Oswal Equity Hybrid Fund, Motilal Oswal Large and Midcap Fund & Motilal Oswal Balanced Advantage Fund. No Load for switch between Options within the Scheme. Further, it is clarified that there will be no exit load charged on a switchout from Regular to Direct plan within the same scheme. No Load shall be imposed for switching between Options within the Scheme
Investment Objective The investment objective is to provide medium to long-term capital appreciation by investing primarily in Large and Midcap stocks. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.
Total Expenses Ratio Direct: 0.65%
Regular: 2.03%

Scrip
Weightage (%)
Equity & Equity Related
Trent Ltd.
6.5%
Global Health Ltd.
5.8%
ICICI Bank Ltd.
5.5%
Fortis Healthcare Ltd.
5.2%
Infosys Ltd.
5.1%
The Federal Bank Ltd.
5.0%
Mankind Pharma Ltd.
4.7%
Titan Company Ltd.
3.7%
HDFC Bank Ltd.
3.1%
IndusInd Bank Ltd.
3.1%
Page Industries Ltd.
3.1%
TVS Motor Company Ltd.
3.0%
Carborundum Universal Ltd.
3.0%
Kaynes Technology India Ltd.
2.9%
Bharat Forge Ltd.
2.8%
Religare Enterprises Ltd.
2.8%
Cholamandalam Investment and Finance Company Ltd
2.7%
Max Financial Services Ltd.
2.7%
State Bank of India
2.6%
Cummins India Ltd.
2.5%
Jubilant Foodworks Ltd.
2.3%
Dalmia Bharat Ltd.
2.3%
Divgi Torqtransfer Systems Ltd.
2.2%
Glenmark Pharmaceuticals Ltd.
2.1%
MedPlus Health Services Ltd.
2.1%
Star Health And Allied Insurance Company Ltd.
1.9%
Crompton Greaves Consumer Electricals Ltd.
1.8%
UltraTech Cement Ltd.
1.8%
KSB Ltd.
1.6%
InterGlobe Aviation Ltd.
1.5%
Axis Bank Ltd.
1.4%
Gujarat Fluorochemicals Ltd.
1.4%
Timken India Ltd.
1.3%
Netweb Technologies India Ltd.
0.2%
Total
99.5%
Net Receivable/Payable
0.5%
Grand Total
100%

Record Date
IDCW
perUnit (₹)
Cum IDCW
NAV
Ex IDCW
NAV
29-March-2022
Direct Plan
1.10
16.0532
14.9532
Regular Plan
1.05
15.4125
14.3625
22-March-2023
Direct Plan
1.14
16.4495
15.3095
Regular Plan
1.08
15.5628
14.4828
Pursuant to payment of IDCW, NAV per unit will fall to the extent of the IDCW payout and statutory levy (if applicable). Face value ₹ 10/-. Past performance may or may not be sustained in future.

1 Year
3 Year
Since Inception
CAGR (%)
Current Value
of Investment
of ₹ 10,000
CAGR
(%)
Current Value
of Investment
of ₹ 10,000
CAGR (%)
Current Value
of Investment
of ₹ 10,000
Scheme
27.5
12,771
28.6
21,262
20.1
19,990
Nifty Large Midcap 250 TRI
20.5
12,061
28.5
21,235
21.5
20,918
Nifty 50 TRI
16.2
11,628
22.7
18,479
16.4
17,796
NAV (₹) Per Unit
(19.9904 as on 31-July-2023)

15.6528

9.4019

10.0000

Date of inception: 17-Oct-19. Incase, the start/end date of the concerned period is non business date (NBD), the NAV of the previous date is considered for computation of returns. The NAV per unit shown in the table is as on the start date of the said period. Past performance may or may not be sustained in the future. Performance is for Regular Plan Growth Option. Different plans have different expense structure. Mr. Aditya Khemani has been appointed as the Fund Manager for equity component since inception; Mr. Rakesh Shetty is the Fund Manager for debt component Managing since 22-Nov-2022. and Mr. Ankush Sood has been appointed as the Fund Manager For Foreign Securities w.e.f. November 11, 2022. The scheme has been in existence for less than 3 years.

1 Year
3 Year
Since Inception
 
Scheme
Nifty Large Midcap
250 TRI
Nifty 50
TRI*
Scheme
Nifty Large Midcap
250 TRI
Nifty 50
TRI*
Scheme
Nifty Large Midcap
250 TRI
Nifty 50
TRI*
Invested Amount
1,20,000

3,60,000

4,50,000

Market Value
1,40,149
1,37,395
1,33,068
4,94,968
4,86,364
4,58,659
6,84,203
6,86,237
6,33,581
Returns (XIRR) %
32.71
28.08
20.90
21.85
20.59
16.41
22.89
23.06
18.54
(as on 31-July-2023)

*Also represents additional benchmark
For SIP returns, monthly investment of ₹ 10,000/- invested on the 1st day of every month has been considered. Performance is for Regular Plan Growth Option. Past performance may or may not be sustained in the future.

(Data as on 31-July-2023) Industry classification as recommended by AMFI

Beta
0.9
Portfolio Turnover Ratio
0.7
Standard Deviation
14.6% (Annualised)
Sharpe Ratio#
1.5 (Annualised)
# Risk free returns based on last overnight MIBOR cut-off of 6.60% (Data as on 31-July-2023)

Regular Plan Growth Option
₹ 19.9904
Regular Plan IDCW Option
₹ 17.5558
Direct Plan Growth Option
₹ 21.2623
Direct Plan IDCW Option
₹ 18.4166
(IDCW= Income Distribution cum capital withdrawal option)

THESE PRODUCTS ARE SUITABLE FOR INVESTORS WHO ARE SEEKING*

  • Long-term capital growth
  • Investment predominantly in equity and equity related instruments of large and midcap stocks
RISKOMETER
BENCHMARK RISKOMETER
NIFTY Large Midcap 250 TRI
* Investors should consult their financial advisers if in doubt about whether the product is suitable for them.